Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches
{{output}}
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide, underscoring the urgent need for innovative therapeutic strategies. Antibody-based therapies have emerged as a transformative approach, offering specificity and the pote... ...
